Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mus
Mus: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 98.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mus, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Mus is 98.0%, measured in 2025. That is the highest value across all 18 years on record.
That represents a change of up 3.2% on the previous year and up 2.1% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Mus peaked at 98.0% in 2025 and was at its lowest, 0.0%, in 2008.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mus, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 10.0% | — |
| 2017 | 84.0% | +740.0% |
| 2018 | 96.0% | +14.3% |
| 2019 | 97.0% | +1.0% |
| 2020 | 96.0% | -1.0% |
| 2021 | 93.0% | -3.1% |
| 2022 | 97.0% | +4.3% |
| 2023 | 91.0% | -6.2% |
| 2024 | 95.0% | +4.4% |
| 2025 | 98.0% | +3.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 28.7% | 0.0% | 97.0% | 10 |
| 2020s | 95.0% | 91.0% | 98.0% | 6 |
Countries ranked near Mus
More health data for Mus
- Pertussis - number of reported cases, gaps filled 0 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Number of neonatal deaths, annual growth rate -0.8929 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.42 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -2.16 % change on previous year (2024)
- Pertussis - number of reported cases, annual growth rate -100 % change on previous year (2011)
- Diphtheria - number of reported cases 0 (2025)
- Pertussis - number of reported cases 0 (2025)
- Total tetanus - number of reported cases 0 (2025)
- Measles - number of reported cases 0 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Mus?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Mus was 98.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mus?
- The highest recorded value was 98.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mus?
- The lowest recorded value was 0.0% in 2008.
- How does Mus rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mus ranks 1st out of 2 regions with data for 2025.
- Where does this Mus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).